Detailed information for compound 1559573

Basic information

Technical information
  • TDR Targets ID: 1559573
  • Name: 2-(3-methoxyphenyl)-N-(4-piperidin-1-ylsulfon ylphenyl)acetamide
  • MW: 388.481 | Formula: C20H24N2O4S
  • H donors: 1 H acceptors: 3 LogP: 2.66 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: COc1cccc(c1)CC(=O)Nc1ccc(cc1)S(=O)(=O)N1CCCCC1
  • InChi: 1S/C20H24N2O4S/c1-26-18-7-5-6-16(14-18)15-20(23)21-17-8-10-19(11-9-17)27(24,25)22-12-3-2-4-13-22/h5-11,14H,2-4,12-13,15H2,1H3,(H,21,23)
  • InChiKey: MAMCZNDDWLPULV-UHFFFAOYSA-N  


Substructure search Similarity search

Network

Hover on a compound node to display the structore

Synonyms

  • 2-(3-methoxyphenyl)-N-[4-(1-piperidylsulfonyl)phenyl]acetamide
  • 2-(3-methoxyphenyl)-N-(4-piperidinosulfonylphenyl)acetamide
  • 2-(3-methoxyphenyl)-N-(4-piperidin-1-ylsulfonylphenyl)ethanamide
  • T5321804
  • ZINC03385999

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens GNAS complex locus Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Brugia malayi GTP-binding regulatory protein Gs alpha-S chain, putative Get druggable targets OG5_131088 All targets in OG5_131088
Echinococcus granulosus guanine nucleotide binding protein Gs subunit Get druggable targets OG5_131088 All targets in OG5_131088
Loa Loa (eye worm) GTP-binding regulatory protein Gs alpha-S chain Get druggable targets OG5_131088 All targets in OG5_131088
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) Get druggable targets OG5_131088 All targets in OG5_131088
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit Get druggable targets OG5_131088 All targets in OG5_131088
Echinococcus granulosus guanine nucleotide binding protein Gs subunit Get druggable targets OG5_131088 All targets in OG5_131088
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) Get druggable targets OG5_131088 All targets in OG5_131088
Echinococcus multilocularis guanine nucleotide binding protein G(s) subunit Get druggable targets OG5_131088 All targets in OG5_131088
Schistosoma mansoni Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) Get druggable targets OG5_131088 All targets in OG5_131088
Schistosoma japonicum ko:K04632 guanine nucleotide binding protein (G protein), alpha stimulating, putative Get druggable targets OG5_131088 All targets in OG5_131088
By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Schistosoma mansoni GTP-binding protein alpha subunit gna GNAS complex locus 394 aa 450 aa 28.7 %
Obtained from network model

Ranking Plot

Putative Targets List

Species Potential target Raw Global Species
Trypanosoma cruzi cytochrome P450 reductase, putative 0.0233 1 1
Schistosoma mansoni NADPH flavin oxidoreductase 0.0117 0.1964 0.0151
Schistosoma mansoni 5-methyl tetrahydrofolate-homocysteine methyltransferase reductase 0.0144 0.3805 0.2407
Loa Loa (eye worm) FAD binding domain-containing protein 0.0233 1 1
Leishmania major NADPH-cytochrome p450 reductase-like protein 0.0233 1 1
Trypanosoma brucei NADPH-cytochrome p450 reductase, putative 0.0233 1 1
Plasmodium vivax NADPH-cytochrome p450 reductase, putative 0.0233 1 1
Toxoplasma gondii flavodoxin domain-containing protein 0.0116 0.1841 0.5
Mycobacterium ulcerans formate dehydrogenase H FdhF 0.0233 1 0.5
Echinococcus granulosus NADPH dependent diflavin oxidoreductase 1 0.0233 1 1
Echinococcus multilocularis NADPH cytochrome P450 reductase 0.0233 1 1
Leishmania major cytochrome P450 reductase, putative 0.0207 0.8159 0.8159
Giardia lamblia Hypothetical protein 0.0207 0.8159 0.5
Loa Loa (eye worm) FAD binding domain-containing protein 0.0144 0.3805 0.3805
Echinococcus multilocularis NADPH dependent diflavin oxidoreductase 1 0.0233 1 1
Plasmodium vivax flavodoxin domain containing protein 0.0207 0.8159 0.8159
Trypanosoma brucei NADPH-dependent diflavin oxidoreductase 1 0.0233 1 1
Trichomonas vaginalis sulfite reductase, putative 0.0233 1 1
Entamoeba histolytica type A flavoprotein, putative 0.0089 0 0.5
Plasmodium falciparum nitric oxide synthase, putative 0.0233 1 1
Entamoeba histolytica type A flavoprotein, putative 0.0089 0 0.5
Loa Loa (eye worm) hypothetical protein 0.0233 1 1
Schistosoma mansoni cytochrome P450 reductase 0.0233 1 1
Trypanosoma cruzi NADPH-dependent FMN/FAD containing oxidoreductase, putative 0.0233 1 1
Trypanosoma cruzi p450 reductase, putative 0.0233 1 1
Entamoeba histolytica type A flavoprotein, putative 0.0089 0 0.5
Entamoeba histolytica type A flavoprotein, putative 0.0089 0 0.5
Trypanosoma cruzi cytochrome P450 reductase, putative 0.0233 1 1
Leishmania major p450 reductase, putative 0.0233 1 1
Chlamydia trachomatis sulfite reductase 0.0144 0.3805 0.5
Brugia malayi FAD binding domain containing protein 0.0144 0.3805 0.3805
Treponema pallidum flavodoxin 0.0089 0 0.5
Trypanosoma brucei NADPH--cytochrome P450 reductase, putative 0.0233 1 1
Echinococcus granulosus NADPH cytochrome P450 reductase 0.0233 1 1
Entamoeba histolytica type A flavoprotein, putative 0.0089 0 0.5
Brugia malayi FAD binding domain containing protein 0.0233 1 1
Toxoplasma gondii flavodoxin domain-containing protein 0.0116 0.1841 0.5
Trichomonas vaginalis NADPH fad oxidoreductase, putative 0.0207 0.8159 0.8159
Trypanosoma brucei NADPH--cytochrome P450 reductase, putative 0.0233 1 1
Giardia lamblia Nitric oxide synthase, inducible 0.0207 0.8159 0.5

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 7.9433 uM PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 23.0999 uM PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] ChEMBL. No reference
Potency (functional) 25.929 uM PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] ChEMBL. No reference
Potency (functional) 28.1838 uM PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 35.4813 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of binding or entry into cells for Lassa Virus. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID463114, AID540249] ChEMBL. No reference
Potency (functional) 79.4328 uM PUBCHEM_BIOASSAY: qHTS Assay for the Inhibitors of Human Flap endonuclease 1 (FEN1). (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488813] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.